Abstract | BACKGROUND/AIMS: METHODS: RESULTS: FR183998 reduced the increases of pro-inflammatory cytokines such as TNF-alpha, interferon-gamma and CINC-1, but enhanced the anti-inflammatory cytokine, IL-10, leading to the prevention of liver injury and increased survival rate in GalN/LPS-treated animals. FR183998 prevented the activation of transcription factor NF-kappaB induced by GalN/LPS. In vivo and in vitro experiments revealed that FR183998 reduced inducible nitric oxide synthase (iNOS) induction and NO production. Further FR183998 decreased levels of iNOS antisense-transcript in GalN/LPS-treated liver and IL-1beta-treated hepatocytes. CONCLUSIONS: FR183998 may reduce a variety of inflammatory mediators such as cytokines and NO in part through the inhibition of NF-kappaB activation, resulting in the prevention of fulminant liver failure, and may inhibit iNOS gene expression at steps of iNOS promoter transactivation and its mRNA stabilization through NF-kappaB and iNOS antisense-transcript, respectively.
|
Authors | Hironori Tanaka, Yoichiro Uchida, Masaki Kaibori, Takeshi Hijikawa, Morihiko Ishizaki, Masanori Yamada, Kosuke Matsui, Takashi Ozaki, Katsuji Tokuhara, Yasuo Kamiyama, Mikio Nishizawa, Seiji Ito, Tadayoshi Okumura |
Journal | Journal of hepatology
(J Hepatol)
Vol. 48
Issue 2
Pg. 289-99
(Feb 2008)
ISSN: 0168-8278 [Print] Netherlands |
PMID | 18096265
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- FR 183998
- Guanidines
- NF-kappa B
- Receptors, Interleukin-1
- Sodium-Hydrogen Exchangers
- Thiophenes
- Tumor Necrosis Factor-alpha
- Interleukin-10
- Nitric Oxide Synthase Type II
|
Topics |
- Animals
- Enzyme Induction
(drug effects)
- Guanidines
(pharmacology)
- Interleukin-10
(physiology)
- Liver
(drug effects, enzymology)
- Liver Failure, Acute
(drug therapy)
- Male
- NF-kappa B
(antagonists & inhibitors)
- Nitric Oxide Synthase Type II
(biosynthesis)
- Rats
- Rats, Sprague-Dawley
- Receptors, Interleukin-1
(antagonists & inhibitors)
- Sodium-Hydrogen Exchangers
(antagonists & inhibitors)
- Thiophenes
(pharmacology)
- Tumor Necrosis Factor-alpha
(physiology)
- Up-Regulation
|